BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

461 related articles for article (PubMed ID: 16034477)

  • 21. Phototherapy in full-term infants with hemolytic disease secondary to ABO incompatibility.
    Osborn LM; Lenarsky C; Oakes RC; Reiff MI
    Pediatrics; 1984 Sep; 74(3):371-4. PubMed ID: 6433318
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review of positive direct antiglobulin tests found on cord blood sampling.
    Dinesh D
    J Paediatr Child Health; 2005; 41(9-10):504-7. PubMed ID: 16150068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ABO system incompatibility: relationship between direct Coombs test positivity and neonatal jaundice.
    Orzalesi M; Gloria F; Lucarelli P; Bottini E
    Pediatrics; 1973 Feb; 51(2):288-9. PubMed ID: 4633082
    [No Abstract]   [Full Text] [Related]  

  • 24. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
    Senterre T; Minon JM; Rigo J
    Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
    Weng YH; Chiu YW
    Chang Gung Med J; 2009; 32(4):400-8. PubMed ID: 19664346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neonatal jaundice--are we over-treating?
    Walsh SA; Murphy JF
    Ir Med J; 2010 Jan; 103(1):28-9. PubMed ID: 20222394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness of double-surface intensive phototherapy versus single-surface intensive phototherapy for neonatal hyperbilirubinemia.
    Boonyarittipong P; Kriangburapa W; Booranavanich K
    J Med Assoc Thai; 2008 Jan; 91(1):50-5. PubMed ID: 18386544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, controlled trial of early intravenous nutrition for prevention of neonatal jaundice in term and near-term neonates.
    Makay B; Duman N; Ozer E; Kumral A; Yeşilirmak D; Ozkan H
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):354-8. PubMed ID: 17325557
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized, triple-blind, placebo-controlled trial of prophylactic oral phenobarbital to reduce the need for phototherapy in G6PD-deficient neonates.
    Murki S; Dutta S; Narang A; Sarkar U; Garewal G
    J Perinatol; 2005 May; 25(5):325-30. PubMed ID: 15716985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate.
    Bakkeheim E; Bergerud U; Schmidt-Melbye AC; Akkök CA; Liestøl K; Fugelseth D; Lindemann R
    Acta Paediatr; 2009 Dec; 98(12):1896-901. PubMed ID: 19703120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of clofibrate on severe neonatal jaundice associated with glucose-6-phosphate dehydrogenase deficiency (a randomized clinical trial).
    Zahedpasha Y; Ahmadpour-Kacho M; Hajiahmadi M; Naderi S; Kamali AA
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):557-61. PubMed ID: 18564698
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prophylactic Phototherapy in ABO Incompatibility.
    Birenbaum HJ
    J Perinatol; 2005 Dec; 25(12):805. PubMed ID: 16311505
    [No Abstract]   [Full Text] [Related]  

  • 35. The benefit of the direct antiglobulin test using gel technique in ABO hemolytic disease of the newborn.
    Chuansumrit A; Siripoonya P; Nathalang O; Sriphaisal T
    Southeast Asian J Trop Med Public Health; 1997 Jun; 28(2):428-31. PubMed ID: 9444034
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of Cord Blood Carboxyhemoglobin in Detecting Significant Hyperbilirubinemia in Term Neonates with ABO Alloimmunization.
    Tıraş M; Can E; Hamilçıkan Ş
    Am J Perinatol; 2022 Sep; 39(12):1321-1325. PubMed ID: 33395710
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early neonatal hyperbilirubinemia using first day serum bilirubin level.
    Agarwal R; Kaushal M; Aggarwal R; Paul VK; Deorari AK
    Indian Pediatr; 2002 Aug; 39(8):724-30. PubMed ID: 12196683
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Efficacy and safety of intravenous immunoglobulins in the management of neonatal hyperbilirubinemia due to ABO incompatibility: a meta-analysis].
    Cortey A; Elzaabi M; Waegemans T; Roch B; Aujard Y
    Arch Pediatr; 2014 Sep; 21(9):976-83. PubMed ID: 25125032
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct antiglobulin test in the prediction of hyperbilirubinemia and predischarge bilirubin levels in infants with mother-infant blood type incompatibility.
    Mehta R; Petrova A
    Pediatr Neonatol; 2021 Jul; 62(4):406-411. PubMed ID: 33967007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk assessment for adverse outcome in term and late preterm neonates with bilirubin values of 20 mg/dL or more.
    Weng YH; Chiu YW; Cheng SW; Hsieh MY
    Am J Perinatol; 2011 May; 28(5):405-12. PubMed ID: 21365530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.